Dilip Shantilal Shanghvi 's Insider Trades & SAST Disclosures

Visit FAQs

No reported Insider Trades available for Dilip Shantilal Shanghvi in the Trendlyne database.

Dilip Shantilal Shanghvi 's has made SAST transactions in Sun Pharma Advanced Research Company Ltd. recently where a Acquisition of 25,280,899 shares done . Disclosure was reported to the exchange on Jan. 10, 2023.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Sun Pharma Advanced
Dilip Shantilal Shanghvi & PACs Promoter Acquisition 11 Jan 2023 25,280,899 213,115,095 (65.67%) 5.78% - 06 Jan 2023
06 Jan 2023		 SAST (29(2)) - Conv. of Warrants
Sun Pharma Advanced
Dilip Shantilal Shanghvi Promoter Acquisition 28 Mar 2022 8,426,966 187,834,196 (69.08%) 0.99% - 21 Mar 2022
21 Mar 2022		 SAST (29(2)) - Conv. of Warrants
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST